Cargando…
Low frequency of parental mosaicism in de novo COL4A5 mutations in X‐linked Alport syndrome
BACKGROUND: Alport syndrome is a progressive hereditary kidney disease clinically presenting with haematuria, proteinuria, and early onset end‐stage renal disease, and often accompanied by hearing loss and ocular abnormalities. The inheritance is X‐linked in the majority of families and caused by se...
Autores principales: | Helle, Ole Magnus Bjorgaas, Pedersen, Torkild Høieggen, Ousager, Lilian Bomme, Thomassen, Mads, Hertz, Jens Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549549/ https://www.ncbi.nlm.nih.gov/pubmed/32812400 http://dx.doi.org/10.1002/mgg3.1452 |
Ejemplares similares
-
Clinical utility gene card for: Alport syndrome – update 2014
por: Hertz, Jens Michael, et al.
Publicado: (2015) -
ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia
por: Tørring, Pernille M., et al.
Publicado: (2017) -
Pigmentary mosaicism: a review of original literature and recommendations for future handling
por: Kromann, Anna Boye, et al.
Publicado: (2018) -
Alport Syndrome: De Novo Mutation in the COL4A5 Gene Converting Glycine 1205 to Valine
por: Antón-Martín, Pilar, et al.
Publicado: (2012) -
De novo mutations in COL4A5 identified by whole exome sequencing in 2 girls with Alport syndrome in Korea
por: Han, Kyoung Hee, et al.
Publicado: (2019)